Nexus Investment Management ULC
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1476329
TORONTO, A6
Position in TMO
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$33,236,157
+$317,410 QoQ
Shares Held
66,292
-1.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
4.68%
of 13F equity value
Holder Rank
#352
of 2,606 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Nexus Investment Management ULC holds $34,644,637 across 3 Diagnostics & Research names. TMO ranks #1 (95.9% of the industry book) .
All Filings in TMO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,236,157 | 66,292 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $32,918,747 | 66,972 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $38,995,246 | 67,297 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $32,756,795 | 67,537 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $24,338,547 | 60,027 | Shares | Sole | 2025-07-28 | |
| No filing history on record for this holder in this stock. | ||||||